UK Markets open in 7 hrs 14 mins
  • NIKKEI 225

    29,683.09
    +84.43 (+0.29%)
     
  • HANG SENG

    25,319.72
    -330.36 (-1.29%)
     
  • GOLD FUTURES

    1,861.20
    -0.20 (-0.01%)
     
  • DOW

    35,870.95
    -60.10 (-0.17%)
     
  • BTC-GBP

    43,311.68
    -238.87 (-0.55%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • Nasdaq

    15,993.71
    +72.14 (+0.45%)
     
  • ^FTAS

    4,152.80
    -11.97 (-0.29%)
     

School of Life Sciences and Technology, Indonesia Wins XVI Fujio Cup Quiz in NCRM NICHE 2021; Rajalakshmi Engineering College, India, Emerge Runners.

·3-min read

Inter-disciplinary event becomes an Innovation platform, attracting global healthcare investors

TOKYO, October 19, 2021--(BUSINESS WIRE)--Alfred Patisenah and Daisy Ramadhani of School of Life Sciences and Technology, Indonesia, won the prestigious Fujio Cup Quiz (FCQ), an active knowledge gaining academic event of NCRM NICHE 2021, on stem cells and regenerative medicine, in a fiercely fought contest among teams representing NIMHANS, Bangalore, India and Kasturba Medical College, the defending champions. Rajalakshmi Engineering College represented by Vigneshwar Ranjan and Vasanta Vaarshini Umapathi came runners in this contest across in three stages with assignments and online live quizzing, conducted since 2006, every October to commemorate the inaugural anniversary of Nichi in Centre for Regenerative Medicine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018006087/en/

The XVI anniversary NCRM NICHE 2021 was held virtually on 17th October 2021, in partnership with Training program in regenerative medicine (TPRM), University of Toronto, Canada, German society for stem cell research (GSZ), Germany, Edogawa evolutionary laboratory of science (EELS), Japan and Enso Healthcare DMCC, Dubai, UAE. The Fujio Cup Quiz was won by School of Life Sciences and Technology, Indonesia, with Rajalakshmi Engineering College, India emerging as runners. (Graphic: Business Wire)

The virtual event had lectures by Prof. Gary Levy, founder, Training program in regenerative medicine, University of Toronto (www.regenmedcanada.com) on lessons learnt during the pandemic and arenas of research for tackling future Covid-19 like viruses (https://www.springer.com/gp/book/9781461357759), Prof. Kazutoshi Mori, Kyoto University, a Lasker prize awardee (https://www.nature.com/articles/nm.3682) on unfolding protein response and endoplasmic reticulum stress (https://elifesciences.org/articles/60970) and Prof. Timothy Kieffer, University of British Columbia & CSO of Viacyte Inc., on encapsulated pancreatic islet cell transplantation for diabetes (https://doi.org/10.3389/fendo.2021.642152). Covid-19 related research were presented by Dr. Tomohiko Kisaka, Hiroshima University, Dr. Stanley Jeremiah, Yokohama City University (https://jamanetwork.com/journals/jama/fullarticle/2765837), Dr. K. Raghavan, JAICARE, Madurai, India (https://www.sciencedirect.com/science/article/pii/S0753332221010271), Dr. K. Ramesh Shankar, NHS Trust - Lincolnshire Partnership, London United Kingdom (https://www.jns-journal.com/article/S0022-510X(21)00248-3/fulltext) and Dr Dedeepiya Devaprasad, who spoke on BREW-COCO method for early prediction of worsening outcome in Covid-19. Prof. Jurgen Hescheler, University of Cologne, Germany, Prof. Naoki Yamamoto, Emeritus Professor, National Centre for Global health and Medicine, Tokyo, Japan and Prof. Pushkala Subramaniam, TN MGR Medical University, India, moderated.

NCRM NICHE an inter-disciplinary event cum innovation platform, spearheading development of novel solutions for Non-alcoholic steatohepatitis (NASH or NAFLD: https://doi.org/10.1101/2021.07.08.451700) and for managing neurodevelopmental disorders like Autism Spectrum Disorders (https://doi.org/10.1101/2021.06.28.21259619), has started attracting multinational investors. Enso Healthcare DMCC, Dubai, UAE, who have partnered with GN Corporation for this active knowledge gaining academic event, being a part of Enso group, a global conglomerate with diverse interests is envisaging to develop path breaking solutions through futuristic research for prevention and management of lifestyle illnesses and in the domains of anti-aging and longevity.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211018006087/en/

Contacts

Samuel JK Abraham
info@gncorporation.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting